These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10588213)

  • 1. Endotoxin: another phantom menace?
    Carlquist JF
    J Am Coll Cardiol; 1999 Dec; 34(7):1982-4. PubMed ID: 10588213
    [No Abstract]   [Full Text] [Related]  

  • 2. Is endotoxemia a risk factor for atherosclerosis?
    Wiedermann CJ; Kiechl S; Willeit J
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):77-9. PubMed ID: 11253743
    [No Abstract]   [Full Text] [Related]  

  • 3. Limitations of the usefulness of the Limulus assay for endotoxin.
    Stumacher RJ; Kovnat MJ; McCabe WR
    N Engl J Med; 1973 Jun; 288(24):1261-4. PubMed ID: 4574106
    [No Abstract]   [Full Text] [Related]  

  • 4. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis.
    Ridker PM
    Circulation; 2002 Jan; 105(1):2-4. PubMed ID: 11772866
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune activation as effect modifier of atherogenesis in chronic infection.
    Ricevuti G; Gritti D; Gasparetto C; Wiedermann CJ
    Int Rev Immunol; 2002; 21(1):27-31. PubMed ID: 12187843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates may inhibit development of atherosclerosis formation through its bactericidal effect on nanobacteria.
    Silay YS; Altundag K; Altundag O; Atik MA; Ozen M
    Med Hypotheses; 2005; 64(6):1239-40. PubMed ID: 15823727
    [No Abstract]   [Full Text] [Related]  

  • 7. Shouldering the risk burden: infection, atherosclerosis, and the vascular endothelium.
    Maniscalco BS
    Circulation; 2003 Mar; 107(11):e74. PubMed ID: 12654621
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of infectious burden on extent and long-term prognosis of atherosclerosis.
    Espinola-Klein C; Rupprecht HJ; Blankenberg S; Bickel C; Kopp H; Rippin G; Victor A; Hafner G; Schlumberger W; Meyer J;
    Circulation; 2002 Jan; 105(1):15-21. PubMed ID: 11772870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new endotoxin-specific assay.
    Obayashi T
    Adv Exp Med Biol; 1990; 256():215-23. PubMed ID: 2183551
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke.
    Mattila KJ; Valtonen VV; Nieminen MS; Asikainen S
    Clin Infect Dis; 1998 Mar; 26(3):719-34. PubMed ID: 9524851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is bacterial DNA a better marker than endotoxin of bacterial translocation in decompensated cirrhosis?
    Vlachogiannakos J; Daikos G; Thalheimer U; Burroughs AK; Ladas SD
    Hepatology; 2011 Jun; 53(6):2140-1; author reply 41-2. PubMed ID: 21425309
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peritonitis, septic shock and endotoxin--an animal experiment study].
    Gögler H; Meckes P
    Z Exp Chir Transplant Kunstliche Organe; 1989; 22(3):159-67. PubMed ID: 2763603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial.
    Pei R; DiMarco DM; Putt KK; Martin DA; Gu Q; Chitchumroonchokchai C; White HM; Scarlett CO; Bruno RS; Bolling BW
    Br J Nutr; 2017 Dec; 118(12):1043-1051. PubMed ID: 29179781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events.
    Blake GJ; Ridker PM
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1512-3. PubMed ID: 12377722
    [No Abstract]   [Full Text] [Related]  

  • 15. Endotoxin and endotoxemia.
    Levin J
    N Engl J Med; 1973 Jun; 288(24):1297-8. PubMed ID: 4703318
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures.
    Thomas LL; Sturk A; Büller HR; ten Cate JW; Spijker RE; ten Cate H
    Am J Clin Pathol; 1984 Aug; 82(2):203-6. PubMed ID: 6465084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammation markers and vascular risk].
    Luc G
    Rev Med Interne; 2004 Jun; 25 Suppl 1():S7-9. PubMed ID: 15165682
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of infectious agents in the understanding of atherosclerosis].
    Capron L
    Rev Med Interne; 2002 May; 23 Suppl 1():8s-9s. PubMed ID: 12108192
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic bacterial infection as a risk factor for atherogenesis. The role of heat shock protein].
    Rabczyński M; Adamiec R
    Przegl Lek; 2004; 61(2):102-4. PubMed ID: 15230151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin inactivation in plasma from patients with gram-negative infection--an in vitro study.
    Olofsson P; Olofsson C; Nylander G; Olsson P
    Prog Clin Biol Res; 1987; 231():323-30. PubMed ID: 3588628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.